Bioavailable 25D was directly measured using a novel assay similar to previously described methods used 4 to measure free vs. bound 25D. (71) The principle of the test is that the concentration of bioavailable 25D 5 as a proportion of the total (% bioavailable 25D) is first measured by a direct binding assay, and then the 6 absolute concentrations of bioavailable 25D3 and 25D2 are calculated by multiplying total 25D3 and 7 25D2 by % bioavailable 25D. Direct measurement of % bioavailable 25D is performed by mixing 5 8 microliters with a fixed concentration of deuterated 25-hydroxyvitamin D3-d3 (100 ng/mL) and diluting 9 this in 1.7 mL of physiologic saline solution (25 mM Tris-HCl pH 7.4, 150 mM NaCl). This is applied to 10 a solid phase extraction column containing beads coated with hydrophobic octyldecyl carbon chains (96-11 well STATA C18E SPE plate, Phenomenex, Torrence, CA). The beads adsorb unbound (bioavailable) 12 25D by hydrophobic binding as the diluted serum (and DBP) passes through the column. The diluted 13 serum is allowed to flow through by gravity, and because the binding of 25D to C18 is reversible, there is 14 a dynamic equilibrium between 25D binding to beads vs. the DBP in solution, and the adsorption of 25D 15 to the column is thus inversely related to the concentration of DBP in the sample. After the diluted serum 16 elutes through the column, the beads are washed with 1.6 mL additional saline to remove any residual 17 DBP. Next, 25-hydroxyvitamin D3-d6 isotopic internal standard is adsorbed to the column, and both the 18 bioavailable 25-hydroxyvitamin D3-d3 and the internal standard are eluted with acetonitrile, derivatized 19 with PTAD, and measured by LC-MS/MS using the same methods described herein to measure total 25D. 20
The assay is calibrated from a standard curve obtained by measuring the concentration of bioavailable 25-21 hydroxyvitamin D3-d3 (using the same methods described above) in assay calibrator standards with 22 known amounts of %bioavailable 25D. The standards are composed of 5% bovine serum albumin in Tris-23 
